Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in young children, elderly and immunocompromised patients worldwide. The RSV fusion (F) protein, which has 5–6 N-glycosylation sites depending on the strain, is a major target for vaccine development....

Full description

Saved in:
Bibliographic Details
Main Authors: Lotte Jacobs, Annelies Leemans, Kim Stobbelaar, Axelle Fransen, Paul Cos, Peter Delputte
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/16/12/1848
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846102418552520704
author Lotte Jacobs
Annelies Leemans
Kim Stobbelaar
Axelle Fransen
Paul Cos
Peter Delputte
author_facet Lotte Jacobs
Annelies Leemans
Kim Stobbelaar
Axelle Fransen
Paul Cos
Peter Delputte
author_sort Lotte Jacobs
collection DOAJ
description Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in young children, elderly and immunocompromised patients worldwide. The RSV fusion (F) protein, which has 5–6 N-glycosylation sites depending on the strain, is a major target for vaccine development. Two to three of these sites are located in the p27 peptide, which is considered absent in virions. Prior research from our group showed that removing the N-glycan at position 116 (N116) in p27 led to higher neutralizing antibody responses and better protection against RSV. In this study, the effect of single, double and triple N-glycan deletion mutations in F p27 was evaluated. Surprisingly, all mutants exhibited similar expressions and functionality to the wild-type F protein. All F p27 glycomutants induced neutralizing antibodies and lowered lung viral loads after an RSV challenge in a mouse model. Although N-glycans in p27 influence immune responses, their exact role in RSV biology remains unclear. Possibly, these glycans, which are mostly conserved, play a role in other aspects of virus replication and biology.
format Article
id doaj-art-4f40d0104e224e539c9b0286b48db2ee
institution Kabale University
issn 1999-4915
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-4f40d0104e224e539c9b0286b48db2ee2024-12-27T14:59:01ZengMDPI AGViruses1999-49152024-11-011612184810.3390/v16121848Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and FunctionalityLotte Jacobs0Annelies Leemans1Kim Stobbelaar2Axelle Fransen3Paul Cos4Peter Delputte5Laboratory for Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp (UA), Universiteitsplein 1 S.7, 2610 Antwerp, BelgiumLaboratory for Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp (UA), Universiteitsplein 1 S.7, 2610 Antwerp, BelgiumLaboratory for Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp (UA), Universiteitsplein 1 S.7, 2610 Antwerp, BelgiumLaboratory for Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp (UA), Universiteitsplein 1 S.7, 2610 Antwerp, BelgiumLaboratory for Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp (UA), Universiteitsplein 1 S.7, 2610 Antwerp, BelgiumLaboratory for Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp (UA), Universiteitsplein 1 S.7, 2610 Antwerp, BelgiumRespiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in young children, elderly and immunocompromised patients worldwide. The RSV fusion (F) protein, which has 5–6 N-glycosylation sites depending on the strain, is a major target for vaccine development. Two to three of these sites are located in the p27 peptide, which is considered absent in virions. Prior research from our group showed that removing the N-glycan at position 116 (N116) in p27 led to higher neutralizing antibody responses and better protection against RSV. In this study, the effect of single, double and triple N-glycan deletion mutations in F p27 was evaluated. Surprisingly, all mutants exhibited similar expressions and functionality to the wild-type F protein. All F p27 glycomutants induced neutralizing antibodies and lowered lung viral loads after an RSV challenge in a mouse model. Although N-glycans in p27 influence immune responses, their exact role in RSV biology remains unclear. Possibly, these glycans, which are mostly conserved, play a role in other aspects of virus replication and biology.https://www.mdpi.com/1999-4915/16/12/1848RSVfusion proteinp27 peptideN-glycosylationDNA immunization
spellingShingle Lotte Jacobs
Annelies Leemans
Kim Stobbelaar
Axelle Fransen
Paul Cos
Peter Delputte
Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality
Viruses
RSV
fusion protein
p27 peptide
N-glycosylation
DNA immunization
title Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality
title_full Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality
title_fullStr Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality
title_full_unstemmed Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality
title_short Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality
title_sort evaluating the impact of n glycan sequon removal in the p27 peptide on rsv f protein immunogenicity and functionality
topic RSV
fusion protein
p27 peptide
N-glycosylation
DNA immunization
url https://www.mdpi.com/1999-4915/16/12/1848
work_keys_str_mv AT lottejacobs evaluatingtheimpactofnglycansequonremovalinthep27peptideonrsvfproteinimmunogenicityandfunctionality
AT anneliesleemans evaluatingtheimpactofnglycansequonremovalinthep27peptideonrsvfproteinimmunogenicityandfunctionality
AT kimstobbelaar evaluatingtheimpactofnglycansequonremovalinthep27peptideonrsvfproteinimmunogenicityandfunctionality
AT axellefransen evaluatingtheimpactofnglycansequonremovalinthep27peptideonrsvfproteinimmunogenicityandfunctionality
AT paulcos evaluatingtheimpactofnglycansequonremovalinthep27peptideonrsvfproteinimmunogenicityandfunctionality
AT peterdelputte evaluatingtheimpactofnglycansequonremovalinthep27peptideonrsvfproteinimmunogenicityandfunctionality